TORONTO, ONTARIO / ACCESS Newswire / December 22, 2025 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands that Quantum BioPharma shareholder...
MCLEAN, Va., Dec. 19, 2025 /PRNewswire/ -- Sierra7, a leader in government healthcare and technology solutions, is proud to announce that...
Avicanna’s evidence-based pathway for cannabinoid-based medicine aligns with the executive order. Avicanna’s 2025 advances across R&D, clinical development, and medical...
LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced InCheck, a comprehensive compliance management...
LAGUNA NIGUEL, Calif., Dec. 18, 2025 /PRNewswire/ -- Alleva, a leader in behavioral health technology, announced InCheck, a comprehensive compliance management...
Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public...
Kazan will take Avalere Health's prestigious policy offering to new heights while Housman will infuse biopharma brands with evolving public...
MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare...
MCLEAN, Va., Dec. 16, 2025 /PRNewswire/ -- ID.me today announced it has entered into a contract with the Centers for Medicare...
Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower...
Mynd Immersive in partnership with the CTA Foundation, AT&T, Lyda Hill Philanthropies, and Select Rehabilitation bring immersive therapeutics to lower...
REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in...
REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in...
REX-8756 is a potent and selective oral STAT6 inhibitor that has shown complete 100% pathway inhibition and potent efficacy in...
Geneva PE's funding of NXXIM will create a cutting-edge AI platform that unifies patient data and empowers clinicians to make...
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or...
Industry collaboration leads to significant improvements in CY 2026 Final Rule but long-term stability remains uncertainDALLAS, Dec. 10, 2025 /PRNewswire/...
Expanding its Portfolio with American Amnion to Serve the Wound Care Needs of Our VeteransPOMPANO BEACH, Fla., Dec. 10, 2025...
Expanding its Portfolio with American Amnion to Serve the Wound Care Needs of Our VeteransPOMPANO BEACH, Fla., Dec. 10, 2025...
Oversubscribed round demonstrates strong investor confidence in Lin Health's neuroscience-based approach to chronic painDENVER, Dec. 9, 2025 /PRNewswire/ -- Lin...